FDA Drug recall D-0025-2022
AirDuo Digihaler 232/14 (fluticasone propionate 232 mcg and salmeterol 14 mcg) Inhalation Powder, Rx Only, Mktd by: Teva Respiratory, LLC,…
- FDA Drug
- Class II
- terminated
- Published 2021-10-27
On 2021-10-27 the FDA classified a Class II recall of AirDuo Digihaler 232/14 (fluticasone propionate 232 mcg and salmeterol 14 mcg) Inhalation Powder, Rx Only, Mktd by: Teva Respiratory, LLC,… by Teva Pharmaceuticals Usa, citing subpotent drug: OOS results of Label Claimed Emitted Dose for salmeterol.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0025-2022 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2021-09-22 |
| Published | 2021-10-27 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Teva Pharmaceuticals Usa |
| Distribution | US |
Product
AirDuo Digihaler 232/14 (fluticasone propionate 232 mcg and salmeterol 14 mcg) Inhalation Powder, Rx Only, Mktd by: Teva Respiratory, LLC, Frazer, PA 19355, Manufactured in Ireland, NDC 59310-136-06
Reason
Subpotent drug: OOS results of Label Claimed Emitted Dose for salmeterol
Identifiers
| code_info | AFR18A |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0025-2022%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.